All Reports Events Blogs Videos
Showing 29 results
  • Blog
    July 29, 2026

    The pharmaceutical technology market is moving beyond point solutions. For years, providers competed by solving specific problems within individual parts of the value chain. Today, differentiation increasingly depends on how well those solutions can understand context,…
  • Provider Recognition
    July 15, 2026

    Pharmaceutical enterprises are accelerating technology investments to modernize operations across the pharmaceutical value chain spanning drug discovery, clinical development, manufacturing, sales and marketing, supply chain and distribution, and pharmacovigilance. As AI, cloud, and data-driven capabilities become…
  • Thematic Report
    March 26, 2026

    Pharmaceutical enterprises are reassessing their IT services sourcing strategies amid moderate growth, budget discipline, and rising innovation expectations. As provider consolidation intensifies, a small group of leading providers continues to capture a disproportionate share of enterprise…
  • Viewpoint
    Jan. 09, 2026

    As pharma enterprises modernize data architectures, automate workflows, and scale AI across the value chain, scientific expertise is becoming essential to realize meaningful outcomes from digital initiatives. Without scientific grounding, digital systems risk producing insights that…
  • LinkedIn Live
    Nov. 19, 2025

    In an evolving landscape where analyst relations (AR) shape market perception and business success, leaders continued to look for proven tactics embraced by experienced AR professionals. Everest Group’s Katrina Menzigian, along with industry experts from other…
  • Category Strategy Templates
    Oct. 17, 2025

    Procurement organizations prioritize reducing costs, managing risks, and creating business value. Category management helps achieve these goals by optimizing category spend, identifying cost-saving opportunities, and improving operational efficiency. In the face of emerging agentic AI use…
  • Viewpoint
    Sep. 26, 2025

    MedTech organizations are under increasing pressure to reimagine stakeholder engagement in response to increasing demand for personalized, connected experiences across the entire device life cycle. Functional silos, disparate technologies, and a lack of cross-functional alignment constrain…
  • Viewpoint
    June 25, 2025

    Life sciences enterprises operate in an increasingly complex engagement landscape due to rising content fatigue, expanding Healthcare Professional (HCP)/patient touchpoints, and growing stakeholder expectations for relevance. Traditional engagement strategies, characterized by fragmented data, siloed operational workflows,…
  • Market Insights™
    March 12, 2024

  • Market Insights™
    March 12, 2024

  • Market Insights™
    March 12, 2024

  • Provider Compendium
    March 08, 2024

    As life sciences enterprises adapt to the post-pandemic market, global macroeconomic uncertainties and geopolitical disruptions are compelling biopharmaceutical and medical devices enterprises to rethink their future growth strategy. These enterprises are rationalizing and restructuring their portfolios,…
  • Webinar
    March 07, 2024

    Last year, the outsourcing industry faced a noticeable slowdown in demand. Now, with nudges at a potential recovery in the latter part of 2024, enterprises in the APAC region should proactively prepare for the possibility of…
  • Thematic Report
    March 07, 2024

    Last year, the outsourcing industry faced a noticeable slowdown in demand. Now, with nudges at a potential recovery in the latter part of 2024, enterprises in the APAC region should proactively prepare for the possibility of…
  • Viewpoint
    Feb. 05, 2024

    In the rapidly evolving life sciences landscape, where the pursuit of innovative therapies and life-saving drugs never ceases, science and technology are increasingly playing a vital role. High-performance Computing (HPC) stands at the forefront of this…
  • PEAK Matrix®
    Jan. 18, 2024

    As life sciences enterprises adapt to the post-pandemic market, global macroeconomic uncertainties and geopolitical disruptions are compelling biopharmaceutical and medical devices enterprises to rethink their future growth strategy. These enterprises are rationalizing and restructuring their portfolios,…
  • Blog
    Nov. 27, 2023

    Deciding betweenServiceNow’s dedicated and shared instances can be challenging for organizations. By comparing the options against seven key parameters ranging from organizational size and business process complexity to the cost of ownership and customization options, enterprises…
  • Blog
    June 16, 2023

    Advances in Generative Artificial Intelligence (GAI) have sparked interest in its potential to drive growth and innovation in the biopharma and medical devices industries. Despite challenges and regulations, the life sciences industry is actively exploring GAI’s…
  • State of the Market
    May 31, 2023

    Amid the global COVID-19 pandemic, the Life Sciences (LS) industry faced unprecedented challenges that prompted the accelerated adoption of IT services across its value chain. To ensure business continuity, LS enterprises swiftly embraced virtual ecosystems facilitated…
  • Provider Compendium
    May 03, 2023

    Core administrative operations are a vital component of healthcare plan and payer organizations. However, with the increasing complexity of delivery and implementation options, the legacy Core Administration Processing Solution (CAPS) falls short. The key core administrative…

Items per page